Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy

In oncotherapy, ruthenium (Ru) complexes are reflected as potential alternatives for platinum compounds and have been proved as encouraging anticancer drugs with high efficacy and low side effects. Cardiovascular diseases (CVDs) are mutually considered as the number one killer globally, and thrombos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Jayakumar, Thanasekaran, Hsu, Chia-Yuan, Khamrang, Themmila, Hsia, Chih-Hsuan, Hsia, Chih-Wei, Manubolu, Manjunath, Sheu, Joen-Rong
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032250/
https://ncbi.nlm.nih.gov/pubmed/29925802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19061818
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars